BB&T Securities’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
$1.36M Sell
7,944
-894
-10% -$153K 0.01% 689
2019
Q2
$1.62M Buy
8,838
+630
+8% +$115K 0.01% 645
2019
Q1
$1.51M Buy
8,208
+586
+8% +$108K 0.01% 662
2018
Q4
$1.26M Buy
7,622
+234
+3% +$38.8K 0.01% 670
2018
Q3
$1.42M Buy
7,388
+328
+5% +$63.2K 0.01% 705
2018
Q2
$1.2M Sell
7,060
-896
-11% -$152K 0.01% 744
2018
Q1
$1.3M Sell
7,956
-1,704
-18% -$278K 0.01% 696
2017
Q4
$1.45M Buy
9,660
+127
+1% +$19K 0.02% 625
2017
Q3
$1.45M Sell
9,533
-3,089
-24% -$470K 0.02% 621
2017
Q2
$1.63M Buy
12,622
+723
+6% +$93.1K 0.02% 572
2017
Q1
$1.3M Buy
11,899
+5,002
+73% +$547K 0.02% 570
2016
Q4
$601K Hold
6,897
0.01% 775
2016
Q3
$601K Buy
6,897
+185
+3% +$16.1K 0.01% 775
2016
Q2
$577K Buy
6,712
+752
+13% +$64.6K 0.01% 752
2016
Q1
$473K Buy
5,960
+591
+11% +$46.9K 0.01% 781
2015
Q4
$675K Sell
5,369
-750
-12% -$94.3K 0.01% 629
2015
Q3
$637K Buy
6,119
+802
+15% +$83.5K 0.01% 622
2015
Q2
$656K Buy
5,317
+477
+10% +$58.9K 0.01% 648
2015
Q1
$5.71M Buy
4,840
+655
+16% +$773K 0.01% 675
2014
Q4
$4.97M Buy
4,185
+633
+18% +$752K 0.01% 705
2014
Q3
$3.99M Sell
3,552
-42
-1% -$47.2K 0.01% 752
2014
Q2
$3.4M Buy
+3,594
New +$3.4M 0.01% 778